Liquid Film Translocation Significantly Enhances Nasal Spray Delivery to Olfactory Region: A Numerical Simulation Study.
droplet deposition
liquid film translocation
nasal spray
nose-to-brain delivery
olfactory dose
vertex-to-floor position
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
18 Jun 2021
18 Jun 2021
Historique:
received:
21
05
2021
revised:
12
06
2021
accepted:
14
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Previous in vivo and ex vivo studies have tested nasal sprays with varying head positions to enhance the olfactory delivery; however, such studies often suffered from a lack of quantitative dosimetry in the target region, which relied on the observer's subjective perception of color changes in the endoscopy images. The objective of this study is to test the feasibility of gravitationally driven droplet translocation numerically to enhance the nasal spray dosages in the olfactory region and quantify the intranasal dose distribution in the regions of interest. A computational nasal spray testing platform was developed that included a nasal spray releasing model, an airflow-droplet transport model, and an Eulerian wall film formation/translocation model. The effects of both device-related and administration-related variables on the initial olfactory deposition were studied, including droplet size, velocity, plume angle, spray release position, and orientation. The liquid film formation and translocation after nasal spray applications were simulated for both a standard and a newly proposed delivery system. Results show that the initial droplet deposition in the olfactory region is highly sensitive to the spray plume angle. For the given nasal cavity with a vertex-to-floor head position, a plume angle of 10° with a device orientation of 45° to the nostril delivered the optimal dose to the olfactory region. Liquid wall film translocation enhanced the olfactory dosage by ninefold, compared to the initial olfactory dose, for both the baseline and optimized delivery systems. The optimized delivery system delivered 6.2% of applied sprays to the olfactory region and significantly reduced drug losses in the vestibule. Rheological properties of spray formulations can be explored to harness further the benefits of liquid film translocation in targeted intranasal deliveries.
Identifiants
pubmed: 34207109
pii: pharmaceutics13060903
doi: 10.3390/pharmaceutics13060903
pmc: PMC8235571
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Drug Deliv. 2016;13(2):265-74
pubmed: 26362143
Phys Fluids (1994). 2020 Dec 1;32(12):123312
pubmed: 33362401
J Aerosol Med. 2007 Spring;20(1):59-74
pubmed: 17388754
PLoS One. 2014 Jan 31;9(1):e86593
pubmed: 24497957
J Pharm Pharmacol. 2004 Jan;56(1):3-17
pubmed: 14979996
Int J Pharm. 2018 Sep 5;548(1):305-313
pubmed: 29960037
Sci Rep. 2020 Jun 29;10(1):10568
pubmed: 32601278
J Neuroimmune Pharmacol. 2007 Mar;2(1):81-6
pubmed: 18040829
Curr Drug Deliv. 2014;11(4):458-71
pubmed: 24655046
Ann Biomed Eng. 2007 Apr;35(4):560-81
pubmed: 17237991
PLoS One. 2021 Jan 28;16(1):e0246007
pubmed: 33507973
Int J Numer Method Biomed Eng. 2013 Jan;29(1):17-39
pubmed: 23293067
Int J Pharm. 2020 Jan 25;574:118911
pubmed: 31809854
Acta Otorrinolaringol Esp. 2012 Sep-Oct;63(5):370-5
pubmed: 22770867
Polymers (Basel). 2020 Jan 24;12(2):
pubmed: 31991675
Expert Opin Drug Deliv. 2013 Jul;10(7):957-72
pubmed: 23586809
Respir Physiol Neurobiol. 2017 Oct;244:56-72
pubmed: 28673875
Otolaryngol Head Neck Surg. 2005 Nov;133(5):735-40
pubmed: 16274802
Pharm Res. 2016 Jun;33(6):1527-41
pubmed: 26943943
Int J Pharm. 2010 Mar 30;388(1-2):82-7
pubmed: 20043981
Sci Rep. 2019 Nov 25;9(1):17450
pubmed: 31768010
Nanomaterials (Basel). 2020 Sep 03;10(9):
pubmed: 32899270
Rhinology. 2006 Jun;44(2):102-7
pubmed: 16792167
Eur Arch Otorhinolaryngol. 2016 Apr;273(4):939-43
pubmed: 26141752
J Aerosol Med. 2001 Summer;14(2):267-80
pubmed: 11681658
Laryngoscope. 2002 Oct;112(10):1806-12
pubmed: 12368620
J Vis Exp. 2016 May 20;(111):
pubmed: 27285852
Inhal Toxicol. 2015;27(8):394-403
pubmed: 26194036
PLoS One. 2019 Sep 6;14(9):e0221330
pubmed: 31490971
J Biomech. 2007;40(2):305-16
pubmed: 16533511
Laryngoscope. 2010 Dec;120(12):2528-31
pubmed: 21058393
Int Forum Allergy Rhinol. 2013 Jan;3(1):48-55
pubmed: 22927179
J Appl Physiol (1985). 2008 Jun;104(6):1761-77
pubmed: 18388247
Clin Otolaryngol. 2021 Mar;46(2):406-411
pubmed: 33326692
Am J Rhinol. 2000 Mar-Apr;14(2):83-6
pubmed: 10793909
Pharm Res. 2014 Aug;31(8):1930-7
pubmed: 24549819
Pharmaceutics. 2014 Jan 29;6(1):26-35
pubmed: 24481172
Ann Neurol. 2003 Mar;53(3):405-9
pubmed: 12601711
Drug Discov Today. 2002 Dec 1;7(23):1184-9
pubmed: 12547019
Pharm Res. 2011 Aug;28(8):1895-904
pubmed: 21499839
J Aerosol Med Pulm Drug Deliv. 2015 Feb;28(1):59-67
pubmed: 24914675
Int J Pharm. 2014 Oct 1;473(1-2):442-57
pubmed: 25062866
Curr Pharm Biotechnol. 2012 Sep;13(12):2355-79
pubmed: 23016642
Pharm Res. 2005 Nov;22(11):1871-8
pubmed: 16091994
Comput Biol Med. 2016 Oct 1;77:40-8
pubmed: 27509293